شاخص‌های التهابی سیستمیک به عنوان پیش‌بینی‌کننده‌های درگیری کبدی در هپاتیت مزمن B: شواهدی از مطالعه کوهورت آذر

Systemic inflammatory indices as predictors of hepatic involvement in chronic hepatitis B: Evidence from the Azar cohort study


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: علی اصغر پوری , سید کاظم میری نژاد , محمد حسین صومی

عنوان کنگره / همایش: بیست و پنجمین کنگره بیماری های گوارش و کبد ایران , Iran (Islamic Republic) , تهران , 2025

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله علی اصغر پوری
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه بیماری های گوارش و کبد
کد مقاله 89469
عنوان فارسی مقاله شاخص‌های التهابی سیستمیک به عنوان پیش‌بینی‌کننده‌های درگیری کبدی در هپاتیت مزمن B: شواهدی از مطالعه کوهورت آذر
عنوان لاتین مقاله Systemic inflammatory indices as predictors of hepatic involvement in chronic hepatitis B: Evidence from the Azar cohort study
نوع ارائه پوستر
عنوان کنگره / همایش بیست و پنجمین کنگره بیماری های گوارش و کبد ایران
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش Iran (Islamic Republic)
شهر محل برگزاری کنگره/ همایش تهران
سال انتشار/ ارائه شمسی 1404
سال انتشار/ارائه میلادی 2025
تاریخ شمسی شروع و خاتمه کنگره/همایش 1404/09/25 الی 1404/09/28
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی Liver and Gastrointestinal Diseases Research Center Tabriz University of Medical Sciences ,Tabriz,Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
علی اصغر پوریاول
سید کاظم میری نژاددوم
محمد حسین صومیچهارم

اطلاعات تفضیلی
hide/show

عنوان متن
کلمات کلیدیHBV,NLR,PLR,Azar cohort
خلاصه مقالهIntroduction: Hepatitis B virus (HBV) infection remains a major global health concern, predisposing patients to chronic liver disease, cirrhosis, and hepatocellular carcinoma. Chronic HBV infection is often accompanied by systemic and hepatic inflammatory responses. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have recently been proposed as accessible markers of systemic inflammation in several chronic diseases. However, their utility in HBV infection requires further clarification. This study aimed to evaluate NLR and PLR in HBV-infected individuals compared with healthy controls, and to explore their association with liver function indices. Methods: A total of 100 participants were enrolled from the Azar Cohort, including 50 patients with chronic HBV infection and 50 age- and sex-matched healthy controls. Blood samples were analyzed for HBV serological markers (HBsAg, HBsAb, HBcAb), complete blood counts (WBC, neutrophils, lymphocytes, and platelets), and liver function tests. NLR and PLR were calculated, and their correlations with biochemical markers of liver injury were assessed. Results: No significant difference in platelet counts was observed between patients and controls (P=0.54). Neutrophil percentages were significantly reduced in patients, whereas lymphocyte percentages were elevated compared with healthy subjects (both P<0.05). Consequently, both NLR and PLR values were significantly decreased in HBV patients relative to controls (P<0.006 and P<0.01, respectively). These alterations reflect a shift in systemic inflammatory balance during HBV infection. Discussion: Chronic HBV infection is associated with reduced NLR and PLR, reflecting an altered systemic inflammatory profile.This decrease is mainly driven by relative lymphocytosis and reduced neutrophil proportions rather than thrombocytopenia.These findings suggest distinct immune modulation in chronic HBV, possibly indicating a virus–host immune equilibrium. Given their low cost and accessibility, NLR and PLR may complement routine tests, though further studies are needed to assess their prognostic value. Conclusion: Our findings indicate that reduced NLR and PLR may serve as potential systemic inflammatory markers in patients with chronic HBV infection. These easily obtainable hematological indices could complement standard liver function tests in assessing inflammatory status and monitoring disease progression. Further large-scale, longitudinal studies are warranted to validate their prognostic utility in predicting clinical outcomes of HBV-related liver disease.

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
certificate-2 ICGH2025.pdf1404/10/15132500دانلود
ICGH2025.Inflammatory Index.jpg1404/10/151988813دانلود